HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia Andrade, I. Articles by Grondin, C. M. Search for Related Content PubMed PubMed Citation Articles by Garcia Andrade, I. Articles by Grondin, C. M.

The Annals of Thoracic Surgery, Vol 44, 607-613, Copyright © 1987 by The Society of Thoracic Surgeons

ARTICLES

Factors influencing early and late survival in patients with combined mitral valve replacement and myocardial revascularization and in those with isolated replacement

I Garcia Andrade, R Cartier, P Panisi, K Ennabli and CM Grondin
Department of Surgery, Montreal Heart Institute, Que, Canada.

During a 5 1/2-year period, 251 patients underwent mitral valve replacement (MVR) at our institution: 76 had combined MVR and coronary artery bypass grafting (CABG), and 175 without major coronary artery disease (CAD) had isolated MVR. In-hospital mortality for MVR + CABG was 13.2% (10/76); it was 8.6% (6/70) when patients with preoperative mechanical support were excluded, 7.9% (5/63) for elective operations, and 8.2% (5/61) for nonischemic mitral disease. Overall, in-hospital mortality for isolated MVR was 6.3% (11/175); it was 4.4% (7/161) excluding patients requiring mechanical support and 3.1% (5/157) for elective operations. Of a host of clinical characteristics in patients with MVR +CABG, few were found to influence in-hospital mortality: age greater than 60 years, degree of incapacitation (New York Heart Association Functional Class IV), previous history of myocardial infarction or congestive heart failure, cardiac enlargement (cardiothoracic index greater than 50%), and ischemic mitral disease (33.3% in-hospital mortality; p less than 0.05). Of the invasive variables, only one influenced in-hospital mortality: wall motion score greater than 10 (31.6% in-hospital mortality; p less than 0.01). Of the operative variables studied, the number of grafts (3 or more: 33.3% in- hospital mortality; p less than 0.05), the need for mechanical support (47.4% in-hospital mortality; p less than 0.0001), and emergency operation (38.5% in-hospital mortality; p less than 0.005) had a significant effect on mortality. The type of mitral lesion, the type of prosthesis, the extent of CAD or the completeness of revascularization, the presence of pulmonary hypertension, and atrial fibrillation appeared to have no influence.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. LeBoutillier III and V. J. DiSesa Valvular and Ischemic Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1175 - 1192. [Full Text]

				M. F. Ibrahim, D. Paparella, J. Ivanov, M. R. Buchanan, and S. J. Brister Gender-related differences in morbidity and mortality during combined valve and coronary surgery J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 959 - 964. [Abstract] [Full Text] [PDF]

				M. LeBoutillier III and V. J. DiSesa Valvular and Ischemic Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1057 - 1074. [Full Text]

				C. M. de Almeida Brandao, P. M. A. Pomerantzeff, L. R. Souza, F. Tarasoutchi, M. Grimberg, J. A. F. Ramires, and S. Almeida de Oliveira Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 922 - 926. [Abstract] [Full Text] [PDF]

				R. G. Seipelt, F. A. Schoendube, J. F. Vazquez-Jimenez, H. Doerge, M. Voss, and B. J. Messmer Combined mitral valve and coronary artery surgery: ischemic versus non-ischemic mitral valve disease Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 270 - 275. [Abstract] [Full Text] [PDF]

				E. L. Hannan, M. J. Racz, R. H. Jones, J. P. Gold, T. J. Ryan, J.-P. Hafner, and O. W. Isom Predictors of mortality for patients undergoing cardiac valve replacements in New York State Ann. Thorac. Surg., October 1, 2000; 70(4): 1212 - 1218. [Abstract] [Full Text] [PDF]

				V. H. Thourani, W. S. Weintraub, J. M. Craver, E. L. Jones, J. P. Gott, W. M. Brown III, J. D. Puskas, and R. A. Guyton Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery Ann. Thorac. Surg., September 1, 2000; 70(3): 778 - 783. [Abstract] [Full Text] [PDF]

				W.R. E. Jamieson, F. H. Edwards, M. Schwartz, J. W. Bero, R. E. Clark, and F. L. Grover Risk stratification for cardiac valve replacement. National Cardiac Surgery Database Ann. Thorac. Surg., April 1, 1999; 67(4): 943 - 951. [Abstract] [Full Text] [PDF]

				B. Yamak, A T. Ulus, S F. Katircioglu, B. Mavitas, A. Saritas, O. Tasdemir, and K. Bayazit Surgery for Combined Rheumatic Valve and Coronary Artery Disease Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 33 - 36. [Abstract] [Full Text] [PDF]

				W. J. Flameng, P. Herijgers, J. Szecsi, P. T. Sergeant, W. J. Daenen, and I. Scheys Determinants of Early and Late Results of Combined Valve Operations and Coronary Artery Bypass Grafting Ann. Thorac. Surg., February 1, 1996; 61(2): 621 - 628. [Abstract] [Full Text]